Amyloid-beta Oligomers Relate to Cognitive Decline in Alzheimer's Disease

Wesley Jongbloed, Kim A. Bruggink, Maartje I. Kester, Pieter-Jelle Visser, Philip Scheltens, Marinus A. Blankenstein, Marcel M. Verbeek, Charlotte E. Teunissen, Robert Veerhuis

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)35-43
JournalJournal of Alzheimer's Disease
Volume45
Issue number1
DOIs
Publication statusPublished - 2015

Keywords

  • Alzheimer's disease
  • amyloid-beta peptides
  • biological markers
  • cerebrospinal fluid
  • cognition
  • dementia
  • disease progression
  • mild cognitive impairment

Cite this

Jongbloed, W., Bruggink, K. A., Kester, M. I., Visser, P-J., Scheltens, P., Blankenstein, M. A., Verbeek, M. M., Teunissen, C. E., & Veerhuis, R. (2015). Amyloid-beta Oligomers Relate to Cognitive Decline in Alzheimer's Disease. Journal of Alzheimer's Disease, 45(1), 35-43. https://doi.org/10.3233/JAD-142136